1. Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom;
2. BioMedicine Design, Pfizer Biotherapeutics Research and Development (R&D), Dublin, Ireland;
3. The Jenner Institute, University of Oxford, Oxford, United Kingdom;
4. Rare Disease Research Unit, Pfizer Inc., Cambridge, MA;
5. BioMedicine Design, Pfizer Biotherapeutics R&D, Cambridge, MA;
6. Pharmacokinetics, Dynamics and Metabolism, Pfizer Biotherapeutics R&D, Andover, MA;
7. Computational Biology Research Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom;
8. Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia;
9. Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia; and
10. Haematology Theme Oxford Biomedical Research Centre, Oxford, United Kingdom